Wyeth Laboratories has hired GCI Healthcare to promote a new treatment for rheumatoid arthritis called Enbrel. Fees are expected to top pounds 100,000 for the trade account which was won following a four-way pitch two weeks ago. Rheumatoid arthritis is a severe inflammatory condition which affects up to 1.5 per cent of the UK population. The agency will target health professionals through seminars and specialist media.
Wyeth Laboratories has hired GCI Healthcare to promote a new
treatment for rheumatoid arthritis called Enbrel. Fees are expected to
top pounds 100,000 for the trade account which was won following a
four-way pitch two weeks ago. Rheumatoid arthritis is a severe
inflammatory condition which affects up to 1.5 per cent of the UK
population. The agency will target health professionals through seminars
and specialist media.
